Rockall Score Calculator

Rockall Score Calculator for Gastroenterology. Higher totals track steeply rising mortality: in the original cohort a complete score of 0 carried near-zero mortality, rising through roughly 5-11 percent in the mid-range to about 25 percent at a score of 7 and over 40 percent at scores of 8 or more. A complete score of 2 or less (or a clinical score of 0) identifies a low-risk group with negligible mortality and low rebleeding, who may be candidates for early discharge or outpatient management. Scores of 3-7 represent intermediate risk warranting admission and endoscopic therapy, and scores of 8 or above flag very high risk needing intensive monitoring and consideration of aggressive haemostatic or surgical intervention. The score should drive disposition and intensity of monitoring, not replace direct assessment of active bleeding.

How this calculator works

The Rockall Score sums points across five variables to estimate the risk of death and rebleeding after acute upper gastrointestinal bleeding. Three clinical variables scored 0-2 make up the pre-endoscopy (clinical) score: age (0 for under 60, 1 for 60-79, 2 for 80+), shock (0 for pulse under 100 and systolic BP 100+, 1 for tachycardia alone, 2 for systolic BP under 100), and comorbidity (0 for none, 2 for cardiac/major disease, 3 for renal failure, hepatic failure, or disseminated malignancy). Two further variables added at endoscopy give the complete score: diagnosis (0 for Mallory-Weiss or no lesion, 1 for all other diagnoses, 2 for upper GI malignancy) and stigmata of recent haemorrhage (0 for none or dark spot, 2 for blood in the tract, adherent clot, or visible/spurting vessel). The clinical score ranges 0-7 and the complete score 0-11.

When to use this calculator

Use it in adults presenting with acute upper GI bleeding to stratify risk of death and rebleeding. The pre-endoscopy portion helps triage at admission, while the complete score is calculated after diagnostic endoscopy and is the version validated for mortality prediction. It applies to both variceal and non-variceal bleeding since diagnosis is a scored input. It is not designed for lower GI bleeding, and unlike the Glasgow-Blatchford Score it is a weaker tool for the specific question of who can avoid intervention entirely, because even a clinical score of 0 is not as clean a discriminator for safe outpatient management.

Inputs used

  • Age
  • Heart rate and systolic blood pressure
  • Comorbid disease
  • Endoscopic diagnosis
  • Endoscopic stigmata

Clinical interpretation

Higher totals track steeply rising mortality: in the original cohort a complete score of 0 carried near-zero mortality, rising through roughly 5-11 percent in the mid-range to about 25 percent at a score of 7 and over 40 percent at scores of 8 or more. A complete score of 2 or less (or a clinical score of 0) identifies a low-risk group with negligible mortality and low rebleeding, who may be candidates for early discharge or outpatient management. Scores of 3-7 represent intermediate risk warranting admission and endoscopic therapy, and scores of 8 or above flag very high risk needing intensive monitoring and consideration of aggressive haemostatic or surgical intervention. The score should drive disposition and intensity of monitoring, not replace direct assessment of active bleeding.

Worked example

A 72-year-old man presents with melaena, pulse 108, systolic BP 105 mmHg, and known ischaemic heart disease. Age 60-79 scores 1, tachycardia with preserved BP scores 1 for shock, and cardiac comorbidity scores 2, giving a clinical (pre-endoscopy) score of 4. Endoscopy reveals a gastric ulcer (diagnosis 1) with a non-bleeding visible vessel (stigmata 2), raising the complete score to 7. A complete score of 7 places him in a high-risk band with an approximate predicted mortality around 40 percent and substantial rebleeding risk, supporting inpatient monitoring, endoscopic haemostasis, and high-dose PPI therapy rather than early discharge.

Limitations and safety notes

The score requires endoscopy findings for the full mortality-validated total, so its most predictive form is unavailable at first contact. The pre-endoscopy clinical score alone underperforms the Glasgow-Blatchford Score for identifying very-low-risk patients safe for outpatient care, and a Rockall clinical score of 0 still misclassifies some patients who need intervention. Comorbidity and stigmata scoring carry inter-observer variability, and the tool was derived in the 1990s before widespread high-dose PPI and modern endoscopic haemostasis, so absolute mortality estimates likely overstate contemporary risk. It is not validated for lower GI bleeding.

Frequently asked questions

What is the difference between the clinical and complete Rockall Score?

The clinical (pre-endoscopy) score uses only age, shock, and comorbidity and ranges 0-7, allowing early triage. The complete score adds endoscopic diagnosis and stigmata of recent haemorrhage, ranges 0-11, and is the version validated to predict mortality.

What Rockall Score is considered low risk?

A complete score of 2 or less, or a clinical score of 0, marks a low-risk group with negligible mortality and low rebleeding risk who may be suitable for early discharge or outpatient management.

Should I use the Rockall Score or the Glasgow-Blatchford Score?

For deciding who can safely avoid endoscopy and be managed as an outpatient, the Glasgow-Blatchford Score performs better and uses no endoscopic data. The Rockall Score is more oriented toward predicting mortality and rebleeding once endoscopy has been done.

Does the Rockall Score apply to variceal bleeding?

Yes. Diagnosis is a scored variable, so variceal and non-variceal causes are both accommodated, though the tool was derived across all-comers with upper GI bleeding rather than a variceal-specific cohort.

Why might modern mortality be lower than the score predicts?

The score was derived in 1993-1994, before routine high-dose PPI therapy and current endoscopic haemostatic techniques, so its absolute mortality percentages tend to overestimate risk in contemporary practice while still ranking patients correctly.

References

  • Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996. PMID: 8675081.
  • Stanley AJ, Laine L, Dalton HR, et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017. PMID: 28053181.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: April 15, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators